Use of influenza vaccine in patients with diabetes, particularly those with complications of cardiac or renal disease

Internal Medicine

Volumn 39, Issue 10, 2000, Pages 862-

  Isotani, H ^a  

^a Hirakata City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADJUVANT THERAPY; ALOPECIA; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; FOOT ULCER; HEART DISEASE; HEART FAILURE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; KIDNEY DISEASE; PNEUMONIA;

EID: 0033778768     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.862     Document Type: Article

References (4)

1. Use of influenza and pneumococcal vaccines in people with diabetes (Technical Review)
2. Immunization and the prevention of influenza and pneumococcal disease in people with diabetes (Position Statement)
3. Prevention and control of influenza, recommendations of the Advisory Committee on Immunization Practices (ACIP)
4. Effect of renal impairment on the pharmacokinetics of intravenous zanamivir